Institute of Inorganic and Analytical Chemistry, Friedrich Schiller University of Jena, Germany.
J Inorg Biochem. 2011 Jan;105(1):6-9. doi: 10.1016/j.jinorgbio.2010.10.006. Epub 2010 Oct 15.
Carbon monoxide releasing molecules (CORMs) deliver controlled amounts of CO to biological targets and organs. The reaction of cysteamine with triirondodecacarbonyl yields dicarbonyl bis(aminoethylthiolato)iron(II) that represents an iron-based CORM with biogenic ligands. X-ray diffraction studies at a single crystal show a cis-arrangement of the carbonyl ligands in trans-position to the amino groups with average Fe-C and C-O distances of 176.8 and 114.8 pm. The CO release is mediated by irradiation with visible light (λ>400 nm). Physiological tests using ion channels sensitive to CO revealed the light- and time-dependent decomposition of CORM-S1 without obvious adverse effects on the cellular level. CORM-S1 is thus suitable for selective CO release and possesses a high potential for therapeutic application.
一氧化碳释放分子(CORMs)将受控量的 CO 递送到生物靶标和器官。半胱胺与三羰基合十三羰基铁反应生成双(氨基乙基硫代)羰基二铁(II),它代表一种具有生物源配体的基于铁的 CORM。单晶的 X 射线衍射研究表明,羰基配体呈顺式排列,与氨基处于反式位置,平均 Fe-C 和 C-O 距离分别为 176.8 和 114.8 pm。CO 的释放是通过可见光(λ>400nm)照射介导的。使用对 CO 敏感的离子通道进行的生理测试表明,CORM-S1 在光和时间的作用下发生分解,在细胞水平上没有明显的不良反应。因此,CORM-S1 适合于选择性 CO 释放,并具有很高的治疗应用潜力。